Milgamma Mono (Benfotiamine)

Benfotiamine, the active ingredient in Milgamma Mono, is a thiamine derivative presented as an oral supplement for oral use. It supports carbohydrate metabolism and is commonly used to help manage conditions associated with impaired thiamine utilization.

GNH USA supplies Milgamma Mono as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑compliant documentation for global distribution.

Benfotiamine is employed primarily in metabolic and neuropathic conditions where thiamine deficiency or dysfunction contributes to disease pathology.

- Diabetic peripheral neuropathy: helps alleviate nerve pain and sensory deficits. - Metabolic support in diabetes: assists in normalizing carbohydrate metabolism. - Advanced glycation end‑product reduction: may decrease tissue accumulation of AGEs.

Benfotiamine is generally well tolerated, but adverse reactions have been reported.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Headache: transient mild headache. - Diarrhea: loose stools. - Skin rash: mild erythema.

Serious or Rare Side Effects: - Hypersensitivity reaction: swelling, itching, or difficulty breathing. - Severe skin eruption: Stevens‑Johnson‑like rash. - Anaphylaxis: rapid onset of systemic allergic response. - Hepatic dysfunction: elevated liver enzymes.

When considering Benfotiamine therapy, several precautionary measures should be observed. - Pregnancy: consult a healthcare professional before use. - Breastfeeding: use with caution and under medical advice. - Renal impairment: monitor renal function and adjust use if needed. - Drug interactions: review concomitant medications for potential effects. - Store below 25°C: keep in the original pack, protect from moisture.

Benfotiamine may affect or be affected by other medicines; awareness of key interactions is important.

Major Interactions (Avoid): - High‑dose thiamine antagonists (e.g., metformin at very high doses): may reduce efficacy. - Certain antibiotics (e.g., tetracyclines): may impair absorption if taken simultaneously.

Moderate Interactions (Monitor Closely): - Loop diuretics: increase thiamine loss, monitor levels. - Statins: observe for muscle‑related symptoms. - Alcohol: chronic use may exacerbate thiamine deficiency.